Comprehensive medication guide to Vuity including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
Most health insurance plans and Medicare do not cover Vuity for presbyopia. Patients typically pay the full cash price out of pocket; no prior authorization is needed since there is no coverage to request.
Estimated Cash Pricing
$87–$162 retail for brand-name Vuity (2.5 mL, 30-day supply); as low as $24–$27 with a GoodRx coupon for the generic pilocarpine 1.25% that launched in August 2025.
Medfinder Findability Score
78/100
Summarize with AI
On this page
Vuity (pilocarpine hydrochloride ophthalmic solution 1.25%) is a prescription eye drop manufactured by Allergan, an AbbVie company. It is the first and only FDA-approved prescription medication specifically indicated for the treatment of presbyopia — age-related blurry near vision — in adults. The FDA approved Vuity on October 29, 2021, and a twice-daily dosing option was approved in 2023.
Presbyopia affects nearly 128 million Americans and approximately 1.8 billion people worldwide. It typically begins around age 40 and is caused by the natural hardening of the eye's lens over time, reducing its ability to focus on nearby objects. Common symptoms include difficulty reading fine print, holding objects at arm's length, and needing more light to see up close.
Vuity is a 1.25% pilocarpine formulation delivered with Allergan's proprietary pHast technology — a pH-optimized formula that absorbs quickly into the eye. A generic pilocarpine 1.25% ophthalmic solution became commercially available in August 2025.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Vuity is a cholinergic muscarinic receptor agonist. When instilled, pilocarpine binds to muscarinic receptors on two smooth muscle structures in the eye: the iris sphincter muscle and the ciliary muscle.
Iris sphincter muscle (miosis/pinhole effect): Pilocarpine contracts the iris sphincter, constricting the pupil (miosis). A smaller pupil creates a pinhole effect that increases depth of focus — similar to how squinting helps you see more clearly. This allows the eye to focus on near and intermediate objects more sharply without needing reading glasses.
Ciliary muscle (accommodation shift): Pilocarpine also contracts the ciliary muscle, releasing tension on the lens zonules and allowing the lens to shift toward a slightly more myopic state, providing additional near focus benefit. Vuity starts working in as early as 15 minutes and lasts approximately 6 hours with once-daily dosing, or up to 9 hours with the optional twice-daily regimen.
1.25% — ophthalmic solution
2.5 mL bottle (30-day supply); 5 mL bottle also available. Instill 1 drop in each eye once daily. A second dose may be administered 3-6 hours after the first.
Vuity is not on the FDA's drug shortage list as of 2026 — it is being manufactured and distributed. However, many patients encounter difficulty filling their prescription because Vuity is a specialty ophthalmic medication that most pharmacies do not stock routinely. Since it is primarily a cash-pay drug with no insurance coverage, pharmacies have less incentive to maintain regular inventory.
A generic pilocarpine 1.25% launched in August 2025, which has improved access somewhat. Independent pharmacies and those familiar with ophthalmic medications are most likely to have it in stock. Mail-order is a reliable alternative for ongoing supply.
The easiest way to find Vuity near you is to use medfinder, which calls pharmacies near you to check who has it in stock and can fill your prescription, then texts you the results.
Vuity is not a controlled substance, so there are no DEA-specific prescribing requirements. Any licensed prescriber can write a Vuity prescription. However, the package insert recommends a dilated retinal examination before initiating therapy — which means eye care specialists are the most appropriate prescribers in practice.
Ophthalmologists (MD/DO): Most common prescribers; can perform full eye exam and retinal evaluation
Optometrists (OD): Can prescribe in most US states; perform comprehensive eye exams including retinal evaluation
Ophthalmology NPs/PAs: Can prescribe under physician oversight in many practices
Telehealth: Some telehealth eye care platforms may prescribe Vuity, though an in-person dilated fundus exam is recommended before the first prescription. Patients with a recent documented normal retinal evaluation may be eligible for telehealth prescribing at the provider's discretion.
No. Vuity (pilocarpine hydrochloride 1.25%) is not a controlled substance and is not scheduled by the DEA. There are no special prescribing restrictions, prescription limits, or refill limitations related to controlled substance status.
Vuity requires a valid prescription from a licensed eye care provider (ophthalmologist or optometrist), but the prescription can be filled at any retail pharmacy, transferred between pharmacies without restriction, and sent to a mail-order pharmacy. There are no quantity limits tied to controlled substance law.
In clinical trials (GEMINI 1 and GEMINI 2), the most common side effects reported in more than 5% of patients were:
Headache (most common; typically improves within 1-2 weeks)
Conjunctival hyperemia (eye redness; usually improves with continued use)
Eye irritation (mild stinging or burning upon instillation)
Retinal detachment or retinal tear (rare; higher risk in patients with pre-existing retinal disease — symptoms: sudden flashing lights, new floaters, shadow in vision)
Sudden vision loss (emergency — seek immediate medical care)
Accommodative spasm (blurred vision with difficulty switching focus between near and far; do not drive if affected)
Know what you need? Skip the search.
Qlosi (pilocarpine 0.4%)
FDA-approved October 2023, commercially available April 2025. Same active ingredient as Vuity but lower concentration, preservative-free formula. Twice-daily dosing up to 8 hours. May be better tolerated than Vuity for patients sensitive to pilocarpine side effects.
Vizz (aceclidine 1.44%)
FDA-approved July 2025, available October 2025. First aceclidine-based presbyopia drop — different active ingredient class. Once-daily, lasts up to 10 hours, preservative-free. A strong alternative for patients who want longer duration or didn't respond to pilocarpine.
Reading glasses
Over-the-counter magnification; immediate, inexpensive, widely available. The simplest option for presbyopia. Requires having glasses available whenever needed.
Multifocal contact lenses
Prescription lenses with multiple focal zones for near and distance vision. Requires professional fitting. A good option for current contact lens wearers seeking continuous presbyopia correction.
Refractive surgery (LASIK monovision / IOL)
Surgical options for permanent presbyopia correction. High upfront cost, invasive. IOL implantation during cataract surgery offers permanent multifocal correction. Not universally appropriate; requires ophthalmology evaluation.
Prefer Vuity? We can find it.
Anticholinergic medications
moderateDrugs with anticholinergic properties (antihistamines like diphenhydramine, bladder medications like oxybutynin, tricyclic antidepressants, certain antipsychotics, scopolamine) can reduce or block Vuity's effectiveness by competing at the same muscarinic receptors.
Ophthalmic mydriatics (tropicamide, atropine eye drops)
moderatePupil-dilating eye drops used for eye exams directly counteract pilocarpine's pupil-constricting effect. Do not use Vuity on the same day as mydriatic eye drops. Allow mydriatics to fully wear off (4-6 hours for tropicamide) before resuming Vuity.
Other topical ophthalmic products
minorAny other eye drops (glaucoma drops, lubricating drops, allergy drops) should be administered at least 5 minutes apart from Vuity to prevent dilution and potential interference.
Cholinesterase inhibitors (donepezil, rivastigmine, galantamine)
moderateAlzheimer's drugs that increase acetylcholine levels. Combined with pilocarpine (also cholinergic), may increase risk of systemic cholinergic effects including sweating, nausea, and bradycardia. Discuss with prescribing physicians.
Soft contact lenses (benzalkonium chloride interaction)
minorVuity contains benzalkonium chloride preservative which can be absorbed by soft contact lenses and cause damage. Remove soft contacts before use; wait 10 minutes after instillation before reinserting.
Vuity represents a meaningful advancement in presbyopia management — the first prescription drop to offer a non-surgical, non-glasses option for the 128 million Americans affected by age-related blurry near vision. It works in as little as 15 minutes, lasts up to 6 hours, and is well tolerated by most patients. The twice-daily dosing option (approved 2023) and the launch of a generic (August 2025) have improved both flexibility and affordability.
The main challenges remain: most insurance plans don't cover it, and it's not stocked at every pharmacy. Using a pharmacy discount card like GoodRx with the generic pilocarpine 1.25% can bring costs to $24-27/fill. Finding a pharmacy that has it in stock is the next hurdle.
If you're struggling to find Vuity at a pharmacy near you, medfinder calls pharmacies in your area to find who has it in stock and texts you the results — saving you the frustration of calling around yourself.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini